Robert L. Nussbaum, Chief Medical Officer at Invitae Corp (NVTA), sold 2,625 shares at $1.41 ($4K) on 2023-03-13, disclosed to the SEC on 2023-03-15.
Seasonal sale ($4k) by Chief Medical Officer — this insider has traded NVTA in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVTA | SELL | 2022-08-18 | $32K | — | Filing → |
| NVTA | SELL | 2022-05-19 | $23K | — | Filing → |
| NVTA | SELL | 2022-03-16 | $262K | — | Filing → |